glp-1 compound podcast 🚨 “70% of people stop GLP-1s within 2 years” according to @drgabriellelyon That stat stops people in their tracks GLP-1 medications are everywhere right

Additionally, there's interest in investigating how FOXO4-DRI might work in conjunction with other senolytic agents or treatments to combat age-related diseases more effectively

Research in Combination: They are being studied together (CagriSema) to explore potential synergistic effects on weight management by targeting both amylin and GLP-1 pathways

It does not make heart disease worse, but it does not actively protect against it either

AOD 9604 is considered safe, especially compared to traditional HGH

Awareness of these potential reactions allows clinicians to better counsel patients and identify medication-related skin findings when they arise